Vancouver’ s GenXys Health Care Systems has partnered with Helix to ensure that “trial-and-error” prescribing becomes a thing of the past, by enabling providers to incorporate actionable personalized medicine across the healthcare continuum.
GenXys is a comprehensive precision prescribing solution with embedded pharmacogenetics and Helix is a leading population genomics company working at the intersection of clinical care, research, and genomics.
Through the partnership, GenXys will provide Helix with a clinical decision support solution for their population health pharmacogenetics offering.
GenXys will act as an interpretation engine for genetic results through its seamless integration into Helix’s Clinical Platform. The interoperability of the GenXys platform will allow for a straightforward incorporation into Helix’s health system partners’ Electronic Health Record systems.
“We are excited to engage in this partnership with GenXys which will help make population genomics even more actionable for clinicians and health systems everywhere,” says James Lu, CEO of Helix.
Together, GenXys and Helix will offer a multi-factorial population health-focused pharmacogenetics solutions combining sophisticated genetic information with tangible, applicable results for health providers at the point of care.
“This partnership will benefit Helix customers as they leverage Helix’s Sequence Once, Query Often™ model; the pharmacogenomics (PGx) query will have the ability to provide actionable insights every time a prescription is required throughout their patients’ lives,” says Karl Pringle, CEO of GenXys.
“This relationship comes at an ideal time as we’ve appointed Dr. Bernard Esquivel as our Chief Medical Officer (CMO). His sophisticated knowledge base and understanding of clinical systems will support the advancement of our partnership with Helix and generate an incredible opportunity for our organization to make a lasting impact in the precision prescribing space as we realize our mission of increasing patient safety, improving population health, and reducing the cost of healthcare.”
Dr. Esquivel is a practicing physician-scientist, senior executive, and international leader with in-depth expertise developing new markets.